CMED China Medical Technologies ADS, Each Representing 10 Ordinary Shares (MM)

CUSIP No. 169483104

13G/A

Page 2 of 6 Pages











1.

NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

AER ADVISORS, INC.


2.

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(see instructions)
(a)
(b)


3.

SEC USE ONLY



4.

CITIZENSHIP OR PLACE OF ORGANIZATION

United States








NUMBER OF
SHARES
BENEFICIALL
Y OWNED BY
EACH
REPORTING
PERSON WITH

5.

SOLE VOTING POWER




6.

SHARED VOTING POWER

1,948,006


7.

SOLE DISPOSITIVE POWER

0


8.

SHARED DISPOSITIVE POWER

0






9.

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING
PERSON

0


10


CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN
SHARES
(see instructions)


11


PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

0%


12


TYPE OF REPORTING PERSON (see instructions)















CUSIP No. 169483104

13G

Page 3 of 6 Pages





Item 1.

(a)
Name of Issuer
CHINA MEDICAL TECHNOLOGIES, INC.




(b)
No. 24 Yong Chang North Road, Beijing Economic-Technological
Development Area, Beijing 100176, People's Republic of China




Item 2.

(a)
Name of Person Filing
AER Advisors, Inc. (AER)




(b)
Address of the Principal Office or, if none, residence
Drake Hill Commons, PO Box 670, North Hampton, NH 03871




(c)
Citizenship
USA




(d)
Title of Class of Securities
American Depositary Shares, each representing 10 Ordinary
Shares, par value $0.10 per share (the Shares)




(e)
CUSIP Number
169483104



Item 3. If this statement is filed pursuant to 240.13d-1(b) or
240.13d-2(b) or (c), check whether the person filing is a:

(a)

Broker or dealer registered under section 15 of the Act (15
U.S.C. 78o).





(b)

Bank as defined in section 3(a)(6) of the Act (15 U.S.C.
78c).





(c)

Insurance company as defined in section 3(a)(19) of the Act
(15 U.S.C. 78c).





(d)

Investment company registered under section 8 of the
Investment Company Act of 1940 (15 U.S.C. 80a-8).





(e)

An investment adviser in accordance with 240.13d-
1(b)(1)(ii)(E);





(f)

An employee benefit plan or endowment fund in accordance with
240.13d-1(b)(1)(ii)(F);





(g)

A parent holding company or control person in accordance with
240.13d-1(b)(1)(ii)(G);





(h)

A savings associations as defined in Section 3(b) of the
Federal Deposit Insurance Act (12 U.S.C. 1813);





(i)

A church plan that is excluded from the definition of an
investment company under section 3(c)(14) of the Investment
Company Act of 1940 (15 U.S.C. 80a-3);





(j)

Group, in accordance with 240.13d-1(b)(1)(ii)(J).




Item 4. Ownership.
Provide the following information regarding the aggregate number and
percentage of the class of securities of the issuer identified in
Item 1.






(a)

Amount beneficially owned: 1,948,006 shares







(b)

Percent of class: 6.0369%






(c)

Number of shares as to which the person has: 0








(i)
Sole power to vote or to direct the vote 0








(ii)
Shared power to vote or to direct the vote 2,026,506 shares








(iii
)
Sole power to dispose or to direct the disposition
of 0








(iv)
Shared power to dispose or to direct the disposition of 1,948,006 shares






Instruction. For computations regarding securities which represent a
right to acquire an underlying security see 240.13d-3(d)(1).
Item 5. Ownership of Five Percent or Less of a Class.
If this statement is being filed to report the fact that as of the
date hereof the reporting person has ceased to be the beneficial
owner of more than five percent of the class of securities, check the
following .
Instruction. Dissolution of a group requires a response to this item.
Item 6. Ownership of More than Five Percent on Behalf of Another
Person.

Item 7. Identification and Classification of the Subsidiary Which
Acquired the Security Being Reported on By the Parent Holding
Company.

Item 8. Identification and Classification of Members of the Group.

Item 9. Notice of Dissolution of Group.

Item 10. Certification.





(a)

The following certification shall be included if the statement
is filed pursuant to 240.13d-1(b):

By signing below I certify that, to the best of my knowledge
and belief, the securities referred to above were acquired and
are held in the ordinary course of business and were not
acquired and are not held for the purpose of or with the
effect of changing or influencing the control of the issuer of
the securities and were not acquired and are not held in
connection with or as a participant in any transaction having
that purpose or effect.







(b)

The following certification shall be included if the statement
is filed pursuant to 240.13d-1(c):








By signing below I certify that, to the best of my knowledge
and belief, the securities referred to above were not acquired
and are not held for the purpose of or with the effect of
changing or influencing the control of the issuer of the
securities and were not acquired and are not held in
connection with or as a participant in any transaction having
that purpose or effect.












CUSIP No. 169483104

13G/A

Page 6 of 6 Pages





 After reasonable inquiry and to the best of my knowledge and
belief, I certify that the information set forth in this statement is
true, complete and correct.

01/27/2012
Date

/s/ Carol O'Leary
Signature

Carol O'Leary, CEO &
President
Name/Title